S1PR5 and cancer: Further studies using fate-mapping of S1pr5 and Gzmc, alongside other approaches to distinguish NK and ILC1 such as Rora reporting36, should be employed across the multiple murine cancer models to further resolve contribution of differentiating cNKs cells versus tissue-residents ILCs.